142 related articles for article (PubMed ID: 34298409)
21. [Lymphoproliferative disorders in Sjögren's syndrome].
Prochorec-Sobieszek M; Wagner T
Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
[TBL] [Abstract][Full Text] [Related]
22. Selective localization of T helper subsets in labial salivary glands from primary Sjögren's syndrome patients.
Maehara T; Moriyama M; Hayashida JN; Tanaka A; Shinozaki S; Kubo Y; Matsumura K; Nakamura S
Clin Exp Immunol; 2012 Aug; 169(2):89-99. PubMed ID: 22774983
[TBL] [Abstract][Full Text] [Related]
23. The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome.
Mitsias DI; Tzioufas AG; Veiopoulou C; Zintzaras E; Tassios IK; Kogopoulou O; Moutsopoulos HM; Thyphronitis G
Clin Exp Immunol; 2002 Jun; 128(3):562-8. PubMed ID: 12067313
[TBL] [Abstract][Full Text] [Related]
24. Non-Hodgkin's lymphoma and Sjögren's syndrome. An immunopathological study of 113 patients.
Janin A; Morel P; Quiquandon I; Farre I; Hatron PY; Bauters F; Gosselin B
Clin Exp Rheumatol; 1992; 10(6):565-70. PubMed ID: 1483307
[TBL] [Abstract][Full Text] [Related]
25. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.
Anaya JM; McGuff HS; Banks PM; Talal N
Semin Arthritis Rheum; 1996 Apr; 25(5):337-46. PubMed ID: 8778989
[TBL] [Abstract][Full Text] [Related]
27. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
Tomás S; Coll J; Reth P; Corominas JM
Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
[TBL] [Abstract][Full Text] [Related]
28. Absence of somatic MYD88 L265P mutations in patients with primary Sjogren's syndrome.
Voulgarelis M; Mavragani CP; Xu L; Treon SP; Moutsopoulos HM
Genes Immun; 2014 Jan; 15(1):54-6. PubMed ID: 24153350
[TBL] [Abstract][Full Text] [Related]
29. CX3CL1 and CX3CR1 expression in tertiary lymphoid structures in salivary gland infiltrates: fractalkine contribution to lymphoid neogenesis in Sjogren's syndrome.
Astorri E; Scrivo R; Bombardieri M; Picarelli G; Pecorella I; Porzia A; Valesini G; Priori R
Rheumatology (Oxford); 2014 Apr; 53(4):611-20. PubMed ID: 24324211
[TBL] [Abstract][Full Text] [Related]
30. Long-term followup of patients with Sjögren's syndrome.
Kruize AA; Hené RJ; van der Heide A; Bodeutsch C; de Wilde PC; van Bijsterveld OP; de Jong J; Feltkamp TE; Kater L; Bijlsma JW
Arthritis Rheum; 1996 Feb; 39(2):297-303. PubMed ID: 8849383
[TBL] [Abstract][Full Text] [Related]
31. Salivary S100A8/A9 in Sjögren's syndrome accompanied by lymphoma.
Jazzar AA; Shirlaw PJ; Carpenter GH; Challacombe SJ; Proctor GB
J Oral Pathol Med; 2018 Oct; 47(9):900-906. PubMed ID: 29998578
[TBL] [Abstract][Full Text] [Related]
32. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism.
Båve U; Nordmark G; Lövgren T; Rönnelid J; Cajander S; Eloranta ML; Alm GV; Rönnblom L
Arthritis Rheum; 2005 Apr; 52(4):1185-95. PubMed ID: 15818675
[TBL] [Abstract][Full Text] [Related]
33. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome.
Theander E; Vasaitis L; Baecklund E; Nordmark G; Warfvinge G; Liedholm R; Brokstad K; Jonsson R; Jonsson MV
Ann Rheum Dis; 2011 Aug; 70(8):1363-8. PubMed ID: 21715359
[TBL] [Abstract][Full Text] [Related]
34. Systemic activation of NLRP3 inflammasome in patients with severe primary Sjögren's syndrome fueled by inflammagenic DNA accumulations.
Vakrakou AG; Boiu S; Ziakas PD; Xingi E; Boleti H; Manoussakis MN
J Autoimmun; 2018 Jul; 91():23-33. PubMed ID: 29551295
[TBL] [Abstract][Full Text] [Related]
35. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
[TBL] [Abstract][Full Text] [Related]
36. Increased CCL25 and T Helper Cells Expressing CCR9 in the Salivary Glands of Patients With Primary Sjögren's Syndrome: Potential New Axis in Lymphoid Neogenesis.
Blokland SLM; Hillen MR; Kruize AA; Meller S; Homey B; Smithson GM; Radstake TRDJ; van Roon JAG
Arthritis Rheumatol; 2017 Oct; 69(10):2038-2051. PubMed ID: 28622456
[TBL] [Abstract][Full Text] [Related]
37. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
Tapinos NI; Polihronis M; Moutsopoulos HM
Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.
Brkic Z; Maria NI; van Helden-Meeuwsen CG; van de Merwe JP; van Daele PL; Dalm VA; Wildenberg ME; Beumer W; Drexhage HA; Versnel MA
Ann Rheum Dis; 2013 May; 72(5):728-35. PubMed ID: 22736090
[TBL] [Abstract][Full Text] [Related]
39. Cluster of differentiation 30 expression in lacrimal gland and conjunctival tissues in patients with Sjögren's syndrome: Case series.
Ogawa A; Ogawa Y; Mukai S; Shimizu E; Kuwana M; Kawakami Y; Tsubota K
Medicine (Baltimore); 2019 Jul; 98(29):e16390. PubMed ID: 31335688
[TBL] [Abstract][Full Text] [Related]
40. Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
Yoshimura S; Nakamura H; Horai Y; Nakajima H; Shiraishi H; Hayashi T; Takahashi T; Kawakami A
Mod Rheumatol; 2016; 26(3):384-90. PubMed ID: 26375433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
